{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:09:11Z","timestamp":1789747751821,"version":"4.0.1"},"reference-count":64,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":243,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adrenocortical carcinoma is a rare and aggressive malignancy for which high-quality evidence to guide clinical decision-making remains limited. This scoping review aimed to map and synthesize the extent, nature, and direction of evidence across five therapeutic domains in the management of adrenocortical carcinoma. Following the Joanna Briggs Institute methodology and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidance, MEDLINE, Embase, and the Cochrane Library were searched without date restrictions. Eligible sources included clinical trials, observational studies, systematic reviews, and clinical guidelines addressing any treatment modality for adrenocortical carcinoma. Data were extracted using a standardized form and synthesized narratively across domains. Evidence visualizations and an intervention-by-domain matrix were developed to identify areas of consistency, uncertainty, and research gaps. Forty-nine studies met the inclusion criteria. Complete tumor resection with negative margins consistently emerged as the strongest prognostic factor. Minimally invasive adrenalectomy showed comparable outcomes only in carefully selected low-risk patients. Adjuvant mitotane demonstrated potential benefit in high-risk disease but not in low- to intermediate-risk patients. In metastatic disease, multimodal management incorporating etoposide, doxorubicin, cisplatin, and mitotane, together with metastasectomy and local therapies, was associated with improved outcomes in selected cases. Recurrence was frequent and often occurred early, particularly in large or invasive tumors. Cortisol-secreting tumors were associated with higher postoperative morbidity and earlier recurrence. Although the available evidence is predominantly retrospective and heterogeneous, consistent patterns emerge that can inform clinical management. This review provides a structured evidence base for future consensus development and highlights priorities for further research.<\/jats:p>","DOI":"10.1530\/eo-26-0079","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:33:36Z","timestamp":1788258816000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-15","source":"Crossref","is-referenced-by-count":0,"title":["Current evidence across the treatment spectrum of adrenocortical carcinoma: a comprehensive scoping review"],"prefix":"10.1530","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8886-5719","authenticated-orcid":true,"given":"Ang\u00e9lica Mar\u00eda","family":"Gonz\u00e1lez-Clavijo","sequence":"first","affiliation":[{"name":"Department of Oncology, Instituto Nacional de Cancerolog\u00eda 1 , ,","place":["Bogot\u00e1, Colombia"]},{"name":"Department of Physiological Sciences, Universidad Nacional de Colombia 2 , ,","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1661-6574","authenticated-orcid":true,"given":"Luis F","family":"Fierro-Maya","sequence":"additional","affiliation":[{"name":"Department of Oncology, Instituto Nacional de Cancerolog\u00eda 1 , ,","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2016-3029","authenticated-orcid":true,"given":"Diego F","family":"Ballen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Instituto Nacional de Cancerolog\u00eda 1 , ,","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3378-2312","authenticated-orcid":true,"given":"Deyanira","family":"Gonz\u00e1lez-Devia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital Universitario Fundaci\u00f3n Santa Fe de Bogot\u00e1 3 , ,","place":["Bogot\u00e1, Colombia"]},{"name":"Department of Endocrinology, Universidad de los Andes 4 , ,","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1757-7952","authenticated-orcid":true,"given":"Andr\u00e9s Arturo","family":"Cu\u00e9llar-Cu\u00e9llar","sequence":"additional","affiliation":[{"name":"Department of Oncology, Instituto Nacional de Cancerolog\u00eda 1 , ,","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-4033","authenticated-orcid":true,"given":"Mauricio","family":"Garc\u00eda-Mora","sequence":"additional","affiliation":[{"name":"Department of Oncology, Instituto Nacional de Cancerolog\u00eda 1 , ,","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0907-7197","authenticated-orcid":true,"given":"Diego M","family":"Gonz\u00e1lez-Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Department of Oncology, Instituto Nacional de Cancerolog\u00eda 1 , ,","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireya","family":"Tapiero-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Oncology, Instituto Nacional de Cancerolog\u00eda 1 , ,","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5942-1035","authenticated-orcid":true,"given":"Alejandro","family":"Rom\u00e1n-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Universidad de Antioquia 5 , ,","place":["Medell\u00edn, Colombia"]},{"name":"Department of Endocrinology, Hospital San Juan de Dios 6 , ,","place":["Rionegro, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0502-439X","authenticated-orcid":true,"given":"Marino","family":"Cabrera","sequence":"additional","affiliation":[{"name":"Department of Oncology, Centro de Tratamiento e Investigaci\u00f3n sobre C\u00e1ncer Luis Carlos Sarmiento Angulo (CTIC) 7 , ,","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas O","family":"S\u00e1nchez-Castillo","sequence":"additional","affiliation":[{"name":"Department of Oncology, Instituto Nacional de Cancerolog\u00eda 1 , ,","place":["Bogot\u00e1, Colombia"]},{"name":"Department of Oncology, Hospital Universitario San Ignacio 8 , ,","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7649-1209","authenticated-orcid":true,"given":"Sara","family":"Correa-Giraldo","sequence":"additional","affiliation":[{"name":"School of Medicine, Universidad Pontificia Bolivariana 9 , ,","place":["Medell\u00edn, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2418-6159","authenticated-orcid":true,"given":"Carlos E","family":"Builes-Monta\u00f1o","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Universidad de Antioquia 5 , ,","place":["Medell\u00edn, Colombia"]},{"name":"Department of Internal Medicine, Hospital Pablo Tob\u00f3n Uribe 10 , ,","place":["Medell\u00edn, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2026091811432441300_bib1","volume-title":"RAND\/UCLA Appropriateness Method User\u2019s Manual","author":"Fitch","year":"2001"},{"key":"2026091811432441300_bib2","doi-asserted-by":"crossref","DOI":"10.46658\/JBIMES-24-01","volume-title":"JBI Manual for Evidence Synthesis","author":"Aromataris","year":"2024"},{"key":"2026091811432441300_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"2026091811432441300_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2026091811432441300_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"2026091811432441300_bib6","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"2026091811432441300_bib7","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"2026091811432441300_bib8","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026091811432441300_bib9","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2026091811432441300_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1245\/s10434-015-4803-x","article-title":"Adrenocortical carcinoma: impact of surgical margin status on long-term outcomes","volume":"23","author":"Margonis","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2026091811432441300_bib11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1245\/s10434-023-14533-w","article-title":"Defining optimal management of non-metastatic adrenocortical carcinoma","volume":"31","author":"Passman","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"2026091811432441300_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00423-016-1462-8","article-title":"Adrenocortical carcinoma surgery-surgical extent and approach","volume":"401","author":"Vanbrugghe","year":"2016","journal-title":"Langenbecks Arch Surg"},{"key":"2026091811432441300_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1530\/EJE-13-0519","article-title":"Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center","volume":"169","author":"Ayala-Ramirez","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2026091811432441300_bib14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00268-001-0024-5","article-title":"Adrenocortical carcinoma: is prognosis different in nonfunctioning tumors? Results of surgical treatment in 31 patients","volume":"25","author":"Favia","year":"2001","journal-title":"World J Surg"},{"key":"2026091811432441300_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00423-011-0852-1","article-title":"Adrenocortical carcinoma: which surgical approach?","volume":"397","author":"Carnaille","year":"2012","journal-title":"Langenbecks Arch Surg"},{"key":"2026091811432441300_bib16","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1245\/s10434-015-4900-x","article-title":"Open versus laparoscopic adrenalectomy for adrenocortical carcinoma: a meta-analysis of surgical and oncological outcomes","volume":"23","author":"Autorino","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2026091811432441300_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1089\/lap.2017.0546","article-title":"Laparoscopic versus open adrenalectomy for localized\/locally advanced primary adrenocortical carcinoma (ENSAT I-III) in adults: is margin-free resection the key surgical factor that dictates outcome? A review of the literature","volume":"28","author":"Mpaili","year":"2018","journal-title":"J Laparoendosc Adv Surg Techn"},{"key":"2026091811432441300_bib18","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.21037\/tau.2020.01.11","article-title":"Open versus minimally invasive surgery for suspected adrenocortical carcinoma","volume":"10","author":"Buller","year":"2021","journal-title":"Transl Androl Urol"},{"key":"2026091811432441300_bib19","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1245\/s10434-022-12711-w","article-title":"Open versus laparoscopic surgery in the management of adrenocortical carcinoma: a systematic review and meta-analysis","volume":"30","author":"Nakanishi","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"2026091811432441300_bib20","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1007\/s00464-021-08827-x","article-title":"A comparison of robotic and laparoscopic minimally invasive adrenalectomy for adrenal malignancies","volume":"36","author":"Hue","year":"2022","journal-title":"Surg Endosc"},{"key":"2026091811432441300_bib21","article-title":"Robotic assisted adrenalectomy as a treatment approach for patients with adrenocortical carcinoma: current evidence","volume":"36","author":"Yiannakopoulou","year":"2022","journal-title":"Surg Endosc"},{"key":"2026091811432441300_bib22","doi-asserted-by":"crossref","first-page":"455.e19","DOI":"10.1016\/j.urolonc.2022.05.021","article-title":"Association of tumor size and surgical approach with oncological outcomes and overall survival in patients with adrenocortical carcinoma","volume":"40","author":"Ginsburg","year":"2022","journal-title":"Urol Oncol"},{"key":"2026091811432441300_bib23","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jso.26418","article-title":"Reassessing the impact of tumor size on operative approach in adrenocortical carcinoma","volume":"123","author":"Hue","year":"2021","journal-title":"J Surg Oncol"},{"key":"2026091811432441300_bib24","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1007\/s00464-012-2772-8","article-title":"Laparoscopic adrenalectomy for malignant lesions: surgical principles to improve oncologic outcomes","volume":"27","author":"Sroka","year":"2013","journal-title":"Surg Endosc"},{"key":"2026091811432441300_bib25","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00268-010-0532-2","article-title":"Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma","volume":"34","author":"Miller","year":"2010","journal-title":"World J Surg"},{"key":"2026091811432441300_bib26","doi-asserted-by":"crossref","first-page":"248.e1","DOI":"10.1016\/j.urolonc.2024.04.003","article-title":"Prognostic significance of lymph node count in surgically treated patients with T(2-4) stage nonmetastatic adrenocortical carcinoma","volume":"42","author":"Assad","year":"2024","journal-title":"Urol Oncol"},{"key":"2026091811432441300_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12010100","article-title":"The effect of surgeon expertise on the outcome of patients with adrenocortical carcinoma","volume":"12","author":"Barac Nekic","year":"2022","journal-title":"J Personalized Med"},{"key":"2026091811432441300_bib28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/biomedicines9080909","article-title":"Surgical management of adrenocortical carcinoma: current highlights","volume":"9","author":"Cavallaro","year":"2021","journal-title":"Biomedicines"},{"key":"2026091811432441300_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/jjco\/hyl127","article-title":"Surgical outcome of stage III and IV adrenocortical carcinoma","volume":"37","author":"Ohwada","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"2026091811432441300_bib30","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.2147\/OTT.S147352","article-title":"Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database","volume":"10","author":"Wang","year":"2017","journal-title":"OncoTargets Ther"},{"key":"2026091811432441300_bib31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.5152\/tud.2017.81598","article-title":"Adrenocortical carcinoma: single center experience","volume":"43","author":"\u015ei\u015fman","year":"2019","journal-title":"Turkish J Urol"},{"key":"2026091811432441300_bib32","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae012","article-title":"Incidence, treatment, and survival of adrenocortical carcinoma in Denmark 2003-2019","volume":"8","author":"Pedersen","year":"2024","journal-title":"J Endocr Soc"},{"key":"2026091811432441300_bib33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1507\/endocrj.EJ21-0277","article-title":"Japanese single-institution analysis of mitotane for patients with adrenocortical carcinoma","volume":"68","author":"Ohmoto","year":"2021","journal-title":"Endocr J"},{"key":"2026091811432441300_bib34","first-page":"1","article-title":"Benefits of adjuvant mitotane after resection of adrenocortical carcinoma: a systematic review and meta-analysis","volume":"2018","author":"Tang","year":"2018","journal-title":"Biomed Res Int"},{"key":"2026091811432441300_bib35","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S2213-8587(23)00193-6","article-title":"Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study","volume":"11","author":"Terzolo","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026091811432441300_bib36","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/jcm8111850","article-title":"Mitotane concentrations influence the risk of recurrence in adrenocortical carcinoma patients on adjuvant treatment","volume":"8","author":"Puglisi","year":"2019","journal-title":"J Clin Med"},{"key":"2026091811432441300_bib37","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3390\/cancers12030740","article-title":"Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma","volume":"12","author":"Puglisi","year":"2020","journal-title":"Cancers"},{"key":"2026091811432441300_bib38","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/cncr.10487","article-title":"A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist","volume":"94","author":"Abraham","year":"2002","journal-title":"Cancer"},{"key":"2026091811432441300_bib39","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41416-021-01513-8","article-title":"Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study","volume":"125","author":"Kimpel","year":"2021","journal-title":"Br J Cancer"},{"key":"2026091811432441300_bib40","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1210\/jc.2019-00029","article-title":"Adjuvant radiation improves recurrence-free survival and overall survival in adrenocortical carcinoma","volume":"104","author":"Gharzai","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091811432441300_bib41","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1210\/jc.2006-1007","article-title":"Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma","volume":"91","author":"Fassnacht","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091811432441300_bib42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijrobp.2015.01.007","article-title":"Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma","volume":"92","author":"Sabolch","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026091811432441300_bib43","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.ijrobp.2010.04.030","article-title":"Adjuvant and definitive radiotherapy for adrenocortical carcinoma","volume":"80","author":"Sabolch","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026091811432441300_bib44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1210\/jc.2012-2367","article-title":"A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma","volume":"98","author":"Habra","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091811432441300_bib45","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1245\/s10434-018-6510-x","article-title":"Adjuvant radiation is associated with improved survival for select patients with non-metastatic adrenocortical carcinoma","volume":"25","author":"Nelson","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"2026091811432441300_bib46","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"key":"2026091811432441300_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113424","article-title":"Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: a population-based study","volume":"196","author":"Debets","year":"2024","journal-title":"Eur J Cancer"},{"key":"2026091811432441300_bib48","doi-asserted-by":"crossref","first-page":"e4698","DOI":"10.1210\/clinem\/dgab449","article-title":"Combination of mitotane and locoregional treatments in low-volume metastatic adrenocortical carcinoma","volume":"106","author":"Boil\u00e8ve","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091811432441300_bib49","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.surg.2019.05.024","article-title":"Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: analysis from the US adrenocortical carcinoma database","volume":"167","author":"Prendergast","year":"2020","journal-title":"Surgery"},{"key":"2026091811432441300_bib50","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3390\/cancers16040702","article-title":"Pulmonary metastasectomy for adrenocortical carcinoma-not If, but when","volume":"16","author":"Carr","year":"2024","journal-title":"Cancers"},{"key":"2026091811432441300_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12672-019-00367-0","article-title":"Metastatic adrenocortical carcinoma: a single institutional experience","volume":"10","author":"Owen","year":"2019","journal-title":"Horm Cancer"},{"key":"2026091811432441300_bib52","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1007\/s00330-020-07019-w","article-title":"Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation","volume":"30","author":"Veltri","year":"2020","journal-title":"Eur Radiol"},{"key":"2026091811432441300_bib53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1245\/s10434-015-4810-y","article-title":"Curative resection of adrenocortical carcinoma: rates and patterns of postoperative recurrence","volume":"23","author":"Amini","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2026091811432441300_bib54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1245\/s10434-009-0716-x","article-title":"Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane","volume":"17","author":"Grubbs","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"2026091811432441300_bib55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/ejendo\/lvad002","article-title":"The management of postoperative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients","volume":"188","author":"Calabrese","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2026091811432441300_bib56","article-title":"Reoperation for recurrent adrenocortical carcinoma: a systematic review and pooled analysis of population-based studies","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Surg"},{"key":"2026091811432441300_bib57","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1210\/jc.2017-02591","article-title":"Mitotane monotherapy in patients with advanced adrenocortical carcinoma","volume":"103","author":"Megerle","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091811432441300_bib58","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1634\/theoncologist.2016-0459","article-title":"Complete responses to mitotane in metastatic adrenocortical carcinoma-a new look at an old drug","volume":"22","author":"Reidy-Lagunes","year":"2017","journal-title":"Oncologist"},{"key":"2026091811432441300_bib59","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.amjsurg.2015.09.020","article-title":"Outcomes after resection of cortisol-secreting adrenocortical carcinoma","volume":"211","author":"Margonis","year":"2016","journal-title":"Am J Surg"},{"key":"2026091811432441300_bib60","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"2026091811432441300_bib61","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S2213-8587(24)00378-4","article-title":"Adrenocortical carcinoma: a practical guide for clinicians","volume":"13","author":"Fassnacht","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026091811432441300_bib62","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.3390\/cancers14112730","article-title":"Loco-regional therapies in oligometastatic adrenocortical carcinoma","volume":"14","author":"Roux","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026091811432441300_bib63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.36401\/JIPO-25-6","article-title":"Phase 2 study of monotherapy with pembrolizumab for advanced adrenocortical carcinoma","volume":"8","author":"Chahla","year":"2025","journal-title":"J Immunother Precis Oncol"},{"key":"2026091811432441300_bib64","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/ejendo\/lvag008","article-title":"Chemo\u2013immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma","volume":"194","author":"Lagan\u00e0","year":"2026","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrine Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article-pdf\/doi\/10.1530\/EO-26-0079\/524550\/eo-26-0079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article-pdf\/doi\/10.1530\/EO-26-0079\/524550\/eo-26-0079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:43:41Z","timestamp":1789746221000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article\/6\/1\/e260079\/78117\/Current-evidence-across-the-treatment-spectrum-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eo-26-0079","relation":{},"ISSN":["2634-4793"],"issn-type":[{"value":"2634-4793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"e260079"}}